We randomly assigned patients in a 1:1 ratio , using computer-generated randomisation lists with stratification for baseline National Institutes of Health Stroke Scale and age , to treatment with desmoteplase ( 90 g/kg ) given 3-9 h after symptom onset or to placebo .